Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 16.806% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. CC1CCN(C(=O)CSc2nnc3ccc(-c4cccnc4)nn23)CC1
b. O=C1CN(C(=O)COc2c(Cl)cccc2Cl)c2ccccc2N1
c. CC(C)(C)c1ccc(C(=O)CSc2n[nH]c(=O)[nH]c2=O)cc1
d. Cc1ccc(C(=O)NCCC(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1C
e. CCN(CC)c1ccc(/C=N/NC(=S)NCc2ccccc2)cc1
Answer: d. Cc1ccc(C(=O)NCCC(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)NCCC(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1C
Cc1ccc(C(=O)NCCC(=O)N2CCC3(CC2)NCCc2[nH]cnc23)cc1C
3,4-dimethyl-N-(3-oxo-3-spiro[1,5,6,7-tetrahydroimidazo[4,5-c]pyridine-4,4'-piperidine]-1'-ylpropyl)benzamide